Tomoko Iehara

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Venues

Pediatric blood & cancer

Cancers

Cancer science

Japanese journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Atsushi Makimoto, Hiroyuki Fujisaki, Kimikazu Matsumoto, Yoshiyuki Takahashi, Yuko Cho, Yoshihiko Morikawa, Yuki Yuza, Tatsuro Tajiri, Tomoko Iehara
Retinoid Therapy for Neuroblastoma: Historical Overview, Regulatory Challenges, and Prospects. Cancers 16 (3) (2024)
Isamu Saeki, Kohmei Ida, Sho Kurihara, Kenichiro Watanabe, Makiko Mori, Tomoro Hishiki, Akiko Yokoi, Junya Fujimura, Shohei Honda, Yuki Nogami, Tomoko Iehara, Takuro Kazama, Masahiro Sekiguchi, Norihiko Kitagawa, Risa Matsumura, Motonari Nomura, Yohei Yamada, Ryo Hanaki, Hide Kaneda, Yuichi Takama, Takeshi Inoue, Yukichi Tanaka, Osamu Miyazaki, Hiroki Nagase, Tetsuya Takimoto, Kenichi Yoshimura, Eiso Hiyama
Successful treatment of young childhood standard-risk hepatoblastoma with cisplatin monotherapy using a central review system. Pediatric blood & cancer (2024)
Atsushi Makimoto, Hiroyuki Fujisaki, Kimikazu Matsumoto, Yoshiyuki Takahashi, Yuko Cho, Yoshihiko Morikawa, Yuki Yuza, Tatsuro Tajiri, Tomoko Iehara
Retinoid Therapy for Neuroblastoma: Historical Overview, Regulatory Challenges, and Prospects. Cancers 16 (3) (2024)
Mitsuru Miyachi, Yohei Sugimoto, Yuya Sugitatsu, Akimasa Tomida, Hideki Yoshida, Kunihiko Tsuchiya, Daisuke Umebayashi, Takumi Yamanaka, Naoya Hashimoto, Yukiko Shishido-Hara, Eiichi Konishi, Tomoko Iehara
Entrectinib treatment induces a durable response against ARHGEF11::NTRK1 fusion gene-positive spinal cord diffuse pediatric-type high-grade glioma. Pediatric blood & cancer (2023)
Satoru Oya, Shinya Osone, Masanori Yoshida, Sota Nishimoto, Yoshihiro Taura, Hideki Yoshida, Mitsuru Miyachi, Tohru Inaba, Eiichi Konishi, Motohiro Kato, Toshihiko Imamura, Tomoko Iehara
Identification of RCC1-LCK as a novel fusion gene in pediatric erythroid sarcoma. Pediatric blood & cancer 69 (9) (2022)
Junichi Hara, Chika Nitani, Hiroyuki Shichino, Tatsuo Kuroda, Tomoro Hishiki, Toshinori Soejima, Tetsuya Mori, Kimikazu Matsumoto, Yoji Sasahara, Tomoko Iehara, Takako Miyamura, Yoshiyuki Kosaka, Tetsuya Takimoto, Akira Nakagawara, Tatsuro Tajiri, null null
Outcome of children with relapsed high-risk neuroblastoma in Japan and analysis of the role of allogeneic hematopoietic stem cell transplantation. Japanese journal of clinical oncology 52 (5) (2022)
Miki Ohira, Yohko Nakamura, Tetsuya Takimoto, Atsuko Nakazawa, Tomoro Hishiki, Kimikazu Matsumoto, Hiroyuki Shichino, Tomoko Iehara, Hiroki Nagase, Takashi Fukushima, Akihiro Yoneda, Tatsuro Tajiri, Akira Nakagawara, Takehiko Kamijo
Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children's Cancer Group Neuroblastoma Committee (JCCG-JNBSG). Biomolecules 12 (1) (2021)
Satoshi Obu, Katsutsugu Umeda, Hiroo Ueno, Mari Sonoda, Keiji Tasaka, Hideto Ogata, Kagehiro Kouzuki, Seishiro Nodomi, Satoshi Saida, Itaru Kato, Hidefumi Hiramatsu, Tatsuya Okamoto, Eri Ogawa, Hideaki Okajima, Ken Morita, Yasuhiko Kamikubo, Koji Kawaguchi, Kenichiro Watanabe, Hideto Iwafuchi, Shigeki Yagyu, Tomoko Iehara, Hajime Hosoi, Tatsutoshi Nakahata, Souichi Adachi, Shinji Uemoto, Toshio Kitawaki, Junko Takita
CD146 is a potential immunotarget for neuroblastoma. Cancer science 112 (11) (2021)
Kenichiro Watanabe, Makiko Mori, Tomoro Hishiki, Akiko Yokoi, Kohmei Ida, Michihiro Yano, Junya Fujimura, Yuki Nogami, Tomoko Iehara, Ken Hoshino, Takeshi Inoue, Yukichi Tanaka, Osamu Miyazaki, Tetsuya Takimoto, Kenichi Yoshimura, Eiso Hiyama
Feasibility of dose-dense cisplatin-based chemotherapy in Japanese children with high-risk hepatoblastoma: Analysis of the JPLT3-H pilot study. Pediatric blood & cancer (2021)
Akimasa Tomida, Shigeki Yagyu, Kayoko Nakamura, Hiroshi Kubo, Kumiko Yamashima, Yozo Nakazawa, Hajime Hosoi, Tomoko Iehara
Inhibition of MEK pathway enhances the antitumor efficacy of chimeric antigen receptor T cells against neuroblastoma. Cancer science 112 (10) (2021)
Tomoko Iehara, Atsushi Manabe, Hajime Hosoi
Statement on the prevention and treatment of COVID-19 in patients with pediatric cancer in Japan. Pediatric blood & cancer 67 (9) (2020)
Tomoo Daifu, Masamitsu Mikami, Hidefumi Hiramatsu, Atsushi Iwai, Katsutsugu Umeda, Mina Noura, Hirohito Kubota, Tatsuya Masuda, Kana Furuichi, Saho Takasaki, Yuki Noguchi, Ken Morita, Toshikazu Bando, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Yasumichi Kuwahara, Tomoko Iehara, Hajime Hosoi, Junko Takita, Hiroshi Sugiyama, Souichi Adachi, Yasuhiko Kamikubo
Suppression of malignant rhabdoid tumors through Chb-M'-mediated RUNX1 inhibition. Pediatric blood & cancer 68 (2) (2020)
Yohei Sugimoto, Yoshiki Katsumi, Tomoko Iehara, Daisuke Kaneda, Chihiro Tomoyasu, Kazutaka Ouchi, Hideki Yoshida, Mitsuru Miyachi, Shigeki Yagyu, Ken Kikuchi, Kunihiko Tsuchiya, Yasumichi Kuwahara, Toshiyuki Sakai, Hajime Hosoi
The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of NOXA. Molecular cancer therapeutics 19 (10) (2020)
Tomoko Iehara, Akihiro Yoneda, Isao Yokota, Hideto Takahashi, Satoshi Teramukai, Takehiko Kamijyo, Atsuko Nakazawa, Tetsuya Takimoto, Atsushi Kikuta, Shigeki Yagyu, Hitoshi Ikeda, Akira Nakagawara, Tatsuro Tajiri, null null
Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee. Pediatric blood & cancer 66 (11) (2019)

Tomoko Iehara.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tomoko Iehara